抗生素课件（英文） Is Resistance Futile.pptVIP

Is Resistance Futile?;Achievements in Public Health;MMWR 1999 48 (29); 621;Antibiotics: the epitome of a wonder drug ;;MRSA;New emerging threats;Clinical Case;Drug;Carbapenemases ;KPC (K. pneumoniae carbapenemase);Streptococcus pneumoniae; Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: 1988-2008;Macrolide-Resistant Pneumococci: Canadian Bacterial Surveillance Network, 1988-2008;S. pneumoniae colonisation: the key to pneumococcal disease;Pneumococcal Vaccines;Introduction of pneumococcal vaccines, Ontario;Invasive pneumococcal disease, elderlyMetropolitan Toronto, 1995-2000;Pediatric invasive pneumococcal diseaseMetropolitan Toronto, 1995-2000;PCV7;MMWR Feb 2008;Introduction of pneumococcal vaccines, Ontario;Pediatric invasive pneumococcal diseaseMetropolitan Toronto, 1995-2007;Invasive pneumococcal disease, elderlyMetropolitan Toronto, 1995-2001;Rates of penicillin and amoxicillin resistance Canada: 1988-2008;;;Worldwide Prevalance of MRSAAmong S. aureus Isolates;MRSA in Canada, 1995-2005;Community -AssociatedMRSA;First Outbreaks of CA-MRSA;Emergence of CA-MRSA Canada;;Community-acquired antibiotic resistance in urinary isolates from adult women in Canada ;Quinolone-resistant Neisseria gonorrhoeae infections in Ontario ;Controlling antimicrobial resistance;Controlling antimicrobial resistance;The average excess age-specific numbers of outpatient visits and courses of antibiotics per 100 children per year ;Controlling antimicrobial resistance;Respiratory Infections are the # 1 Reason for Office Visits;Nearly Two-thirds of all Oral Solid Antibiotic Prescriptions are for Sinusitis and Bronchitis;Usage of antibiotics in Europe vs. pneumococcal penicillin I/R 1997;Controlling antimicrobial resistance;;Prevalence of Erythromycin Resistance Among Pneumococci by Prior Macrolide Use;Relative Risk for Infection With Fluoroquinolone-Resistant Pneumococci by Prior Antibiotic Use;;WHO statement 2000;Fluoroquinolone-Resistant Pneumococci: C